Rua Bioscience Limited (NZE:RUA)

Market Cap	6.83M
Revenue (ttm)	1.83M
Net Income (ttm)	-3.46M
Shares Out	244.04M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	54,882
Average Volume	135,483
Open	0.0280
Previous Close	0.0280
Day's Range	0.0280 - 0.0280
52-Week Range	0.0230 - 0.0590
Beta	0.43
RSI	40.74
Earnings Date	Nov 26, 2025

About Rua Bioscience

Rua Bioscience Limited engages in the research, development, and sale of pharmaceutical products in New Zealand and internationally. It offers cannabis-derived medicines. The company is also involved in seed production and genetic discovery related activities. In addition, it engages in plant breeding business, as well as involved in plant research activities. Rua Bioscience Limited was formerly known as Hikurangi Cannabis Company Limited and changed its name to Rua Bioscience Limited in October 2019. The company was founded in 2016 and is base...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: New Zealand
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: RUA

Financial Performance

In 2025, Rua Bioscience's revenue was 1.83 million, an increase of 477.39% compared to the previous year's 316,350. Losses were -3.46 million, -74.81% less than in 2024.